Lanutan, Sheila Jane B.
HRN: 13-25-75 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2022
CEFUROXIME 750MG (VIAL)
10/09/2022
10/16/2022
IV
750mg
Q8 Hrs
LTCS
Waiting Final Action
10/10/2022
CEFUROXIME 500MG (TAB)
10/10/2022
10/16/2022
PO
1tab
Q12H
S/p LTCS
Waiting Final Action